Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review (Q30842757)

27 June 2017

1 reference

title

Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review (English)

1 reference

Adaptive radiation therapy

27 June 2017

0 references

0 references

1 reference

Plevová P

1

1 reference

PubMed ID

10694945

27 June 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

27 June 2017

1 reference

27 June 2017

35

1 reference

27 June 2017

5

1 reference

27 June 2017

453-470

1 reference

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity.

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: protective role of IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Initiation of acute phase response and synthesis of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Apoptosis in cancer therapy: crossing the threshold

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Programmed cell death and radioresistance

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Cytotoxic Drugs, Programmed Cell Death, and the Immune System: Defining New Roles in an Old Play

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Herpes simplex virus and oral mucositis in children with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Irradiation mucositis: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Clinical evaluation of MGI 209, an anesthetic, film-forming agent for relief from painful oral ulcers associated with chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

An oral disease prevention program for patients receiving radiation and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Impact of improved dental services on the frequency of oral complications of cancer therapy for patients with non-head-and-neck malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

National Institutes of Health consensus development conference statement: oral complications of cancer therapies: diagnosis, prevention, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Management of oral mucositis during local radiation and systemic chemotherapy: A study of 98 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Oral findings in irradiated edentulous patients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Management of mucositis in oral irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Mouth care for nasopharyngeal cancer patients undergoing radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

1 reference

7 January 2021

Pathways of gastrointestinal protection and repair: mechanisms of action of sucralfate

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Sucralfate suspension for stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Sucralfate suspension for mouth ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Oral sucralfate suspension for mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Sucralfate prophylaxis of fluorouracil-induced stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Sucralfate for radiation mucositis: results of a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Vitamin E and glutathione are required for preservation of microsomal glutathione S-transferase from oxidative stress in microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Vitamin E in the treatment of chemotherapy-induced mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

The use of tretinoin as oral mucositis prophylaxis in bone marrow transplantation patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Oral complications of acute leukemia: prophylactic impact of a chlorhexidine mouth rinse regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Yeast flora of the mouth and skin uring and after irradiation or oral and laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Treatment for irradiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

In vivo metabolism and anti-inflammatory activity of benzydamine hydrochloride in rats treated with carrageenin

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

A controlled study of benzydamine oral rinse ("Difflam") in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Comparative evaluation of benzydamine oral rinse in children with antineoplastic-induced stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Topical 5-aminosalicylic acid: a treatment for aphthous ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Successful treatment of genital and oral ulceration in Behçet's disease with topical 5-aminosalicylic acid (5-ASA)

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

The epidermal growth factor (EGF).

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Assessment of epidermal growth factor in oral secretions of patients receiving radiation therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration. A phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Use of misoprostol during pregnancy and Möbius' syndrome in infants

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Local prostaglandin E2 in patients with oral malignancies undergoing chemo- and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Local benefit of prostaglandin E2 in radiochemotherapy-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Prostaglandin E2 potentiates interleukin-1 beta induced interleukin-6 production by human gingival fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Palliation of radiation-related mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effects of stimulated repopulation on oral mucositis during conventional radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

High-dose methotrexate: a critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Methotrexate-induced oral mucositis and salivary methotrexate concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Oral mucositis in children with acute lymphoblastic leukemia after high-dose methotrexate treatment without delayed elimination of methotrexate: relation to pharmacokinetic parameters of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Monitoring of methotrexate and 7-hydroxymethotrexate in saliva from children with acute lymphoblastic leukemia receiving high-dose consolidation treatment: relation to oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Allopurinol modulation of high-dose fluorouracil toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Modulation of 5-fluorouracil toxicity by allopurinol in man

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Prophylactic action of allopurinol against chemotherapy-induced stomatitis--inhibition of superoxide dismutase and proteases

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Decreased acute toxicity by using midline mucosa-sparing blocks during radiation therapy for carcinoma of the oral cavity, oropharynx, and nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Inhibition of fluorouracil-induced stomatitis by oral cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Ice pops to prevent melphalan-induced stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Low-energy laser treatment of pain and wounds: hype, hope, or hokum?

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

CORRESPONDENCE: Soft-Laser Therapy for Iatrogenic Mucositis in Cancer Patients Receiving High-Dose Fluorouracil: A Preliminary Report

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Helium-neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Response of oral leukoplakia to beta-carotene

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Seasonal allergic rhinitis. Newer treatment approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Immune response modulation by pentoxifylline in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Prostaglandin inhibitor and radiotherapy in advanced head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis?

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Intravenous immunoglobulin as prophylaxis of chemotherapy-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Intravenous immunoglobulins and transforming growth factor beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

GM-CSF after allogeneic bone marrow transplantation: accelerated recovery of neutrophils, monocytes and lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Cancer chemotherapy associated symptomatic stomatitis. Role of herpes simplex virus (HSV)

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Oral herpes simplex infections in patients with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Acyclovir prophylaxis and fever during remission-induction therapy of patients with acute myeloid leukemia: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Intracellular muscle free amino acids—their measurement and function

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

The potential use of parenteral dipeptides in clinical nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Glutamine and the preservation of gut integrity.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of glutamine on protein synthesis in isolated intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Mucositis management practices for hospitalized patients: national survey results

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

[Prevention and therapy of acute radiation injuries of the skin and mucosa. I. Results of a German multicenter questionnaire].

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2899%2900033-0

7 January 2021

10.1016/S1368-8375(99)00033-0

Identifiers

DOI

1 reference

27 June 2017

1 reference

PubMed ID

10694945